Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02181621 · ClinicalTrials.gov registry record · NA
A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs
A NA study, sponsored by Smith & Nephew.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02181621 is a NA study that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 19 participants.
The verdict
NCT02181621, a NA study, was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study is a prospective comparative study to determine if an Iodine Gel (Iodosorb◊) is better than standard dressing (Solosite◊ gel) in disruption of biofilm (small microorganism bacteria similar to plaque on teeth) on the wound bed diabetic foot ulcers. ◊ Trademark of Smith \& Nephew
Interventions
- DEVICE Iodosorb
- DEVICE Solosite gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02181621
The ClinicalTrials.gov registry entry for NCT02181621 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iodosorb is the first listed.
NCT02181621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02181621 about?
NCT02181621 is a clinical study titled "A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs". This study is a prospective comparative study to determine if an Iodine Gel (Iodosorb◊) is better than standard dressing (Solosite◊ gel) in disruption of biofilm (small microorganism bacteria similar to plaque on teeth) on the wound bed diabetic foot ulcers. ◊ Trademark of Smith \& Nephew
What is the current status of trial NCT02181621?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2014-08. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02181621?
The interventions under investigation include: Iodosorb (DEVICE), Solosite gel (DEVICE).
Who is sponsoring clinical trial NCT02181621?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.